Diabetes and Cardiovascular Diseases Risk Assessment in Community Pharmacies: An Implementation Study

Sarah Rondeaux, Tessa Braeckman, Mieke Beckwe, Natacha Biset, Joris Maesschalck, Nathalie Duquet, Isabelle De Wulf, Dirk Devroey, Carine De Vriese

Onderzoeksoutput: Other contribution

Samenvatting

The implementation of a new service is often challenging when translating research findings into routine clinical practices. This paper presents the results of the implementation study of a pilot project for a diabetes and cardiovascular diseases risk-assessment service in Belgian community pharmacies. To evaluate the implementation of the service, a mixed method was used that follows the RE-AIM framework. During the testing stage, 37 pharmacies participated, including five that dropped out due to a lack of time or COVID-19-related temporary obligations. Overall, 502 patients participated, of which 376 (74.9%) were eligible for according-to-protocol analysis. Of these, 80 patients (21.3%) were identified as being at high risk for the targeted diseases, and 100 (26.6%) were referred to general practice for further investigation. We presented the limited effectiveness and the key elements influencing optimal implementation. Additional strategies, such as interprofessional workshops, a data-sharing platform, and communication campaigns, should be considered to spread awareness of the new role of pharmacists. Such strategies could also promote collaboration with general practitioners to ensure the follow-up of patients at high risk. Overall, this service was considered easy to perform and feasible in practice but would require financial and external support to ensure its effectiveness, sustainability, and larger-scale implementation.
Originele taal-2English
Mijlpalentype toekennenThis paper presents the results of the implementation study of a pilot project for a diabetes and cardiovascular diseases risk-assessment service in Belgian community pharmacies.
OutputmediaOnline
Aantal pagina's1
Volume19
DOI's
StatusPublished - 17 jul 2022

Bibliografische nota

Funding Information:
We are very grateful to the local professional organisations and our sponsors, the Association of Belgian Pharmacies (APB), Citylabs, the medical laboratory of the Cliniques universitaires Saint-Luc, the Federation of Associations of the General Practitioners of Brussels (FAMGB), the Scientific Society of General Practitioners (SSMG), the Union of Brussels pharmacists (UPB) and the Professional Union of French-speaking Dietitians (UPDLF), for their expertise and support during the project and study. We would also like to thank Stephan Van den Broucke and Sandrine Roussel for their coordination and partnership with the Innoviris project. Finally, we thank the Fonds Van Buuren and the Fondation Jaumotte Demoulin, which offered a grant to S.R. to finalise her research and thesis.

Funding Information:
APB financed the risk-assessment pilot project with its own resources. The researchers evaluating the implementation were financed by Innoviris, a public organisation funding and supporting research and innovation in the Brussels-Capital Region.

Publisher Copyright:
© 2022 by the authors.

Copyright:
Copyright 2022 Elsevier B.V., All rights reserved.

Citeer dit